PRGO
Perrigo Company PLC
ACTIONABLEMethodology gates passed
Position levels
Currenttoday
USD 12.84
Buy <=wait / entry
USD 10.50
Trim >=take some off
USD 14.50
Thesis breakA renewed FDA warning letter or import alert at a Perrigo manufacturing site, a ...
-
Scenario-weighted conviction
| Probability | Score | Contribution | |
|---|---|---|---|
| Bull case | 29% | 100 / 100 | 29.0 |
| Base case | 50% | 62 / 100 | 31.0 |
| Bear case | 21% | 10 / 100 | 2.1 |
| Weighted conviction | 62 / 100 - OPPORTUNISTIC BUY | ||
Top risks
- M&A activity: Completed divestiture of Dermacosmetics business for upfront proceeds of approximately EUR 306 million to support debt reduction
- Earnings or guidance changes: Q2 2026 EPS beat of $0.50 actual vs $0.36 estimate (38.89% surprise); maintained full-year 2026 outlook with expectation for second half improvement
- Earnings or guidance changes: Specialty Care segment net sales and operating income growth led by Compeed, Opill, and ellaOne brands